identif
potenti
sarscov
antivir
compound
progress
swiftli
thank
part
avail
bioinformat
viru
structur
data
antivir
target
sarscov
superfamili
helicas
serin
proteinas
low
micromolar
ec
valu
report
papainrel
cystein
proteinas
may
prove
unsuit
target
coronaviru
molecular
clone
lack
one
two
known
cleavag
site
enzym
display
minor
growth
defect
cell
cultur
confirm
put
viral
enzym
includ
polymeras
poli
u
specif
endoribonucleas
homolog
sadenosylmethioninedepend
ribos
cyclic
phosphodiesteras
repres
plausibl
antisar
target
antivir
target
interact
viral
spike
protein
receptor
spikemedi
fusion
event
show
micromolarscal
effici
cell
cultur
report
sever
group
also
report
antivir
vitro
efficaci
sirna
antisens
agent
direct
singlestrand
rna
known
act
two
gener
mechan
caus
damag
rna
strand
contain
complementari
target
sequenc
prime
endogen
rnase
h
activ
stabli
bind
steric
interfer
target
rna
function
phosphorodiamid
morpholino
oligom
pmo
act
latter
mechan
duplex
specif
rna
sequenc
watsoncrick
base
pair
form
steric
block
frequent
success
target
strategi
pmobas
gene
knockdown
involv
interf
translat
initi
mask
splice
site
recent
demonstr
antivir
effect
vitro
one
peptideconjug
pmo
ppmo
complementari
aug
translat
start
site
region
murin
coronaviru
replicas
polyprotein
reason
antivir
effect
ppmo
might
improv
choos
conserv
rna
sequenc
element
secondari
structur
critic
replic
transcript
host
factor
interact
target
report
demonstr
antisensemedi
suppress
viral
replic
achiev
target
conserv
rna
element
requir
viral
rna
synthesi
translat
pmo
complementari
genom
positivesens
strand
design
bind
region
identifi
conserv
note
literatur
critic
viral
rna
synthesi
synthes
fig
pmo
coval
link
peptid
nh
rrrrrrrrrffcconh
nh
rrrrrffrrrrcconh
design
r
f
r
f
r
respect
type
peptideconjug
pmo
henceforth
refer
ppmo
use
interchang
studi
cell
treat
pmo
least
viabl
measur
mtt
viabil
assay
data
shown
test
ppmo
correl
antivir
efficaci
reduct
viral
titer
rate
spread
vitro
viral
subgenom
rna
load
cell
pretreat
ppmo
h
prior
low
multipl
inocul
supernat
collect
titrat
h
later
fig
effect
ppmo
decreas
viral
titer
threshold
detect
experi
shown
reduc
peak
titer
assay
shown
exhibit
robust
antivir
activ
low
micromolar
rang
next
test
effect
ppmo
viral
persist
spread
establish
infect
perform
plaques
reduct
assay
assay
cell
treat
ppmo
h
inocul
standard
amount
sarscov
plaqu
diamet
measur
h
inocul
ppmo
effect
reduc
sarscov
spread
cell
cultur
fig
reason
inhibit
viral
growth
correspond
decreas
viral
rna
level
whether
inhibit
replicas
express
interfer
discontinu
rna
synthesi
leader
tr
altern
mechan
coronavirus
produc
nest
set
subgenomelength
rna
speci
infect
cell
investig
genom
subgenom
rna
product
h
lowmultipl
inocul
rtpcr
product
specif
eight
subgenom
rna
speci
strongli
amplifi
untreat
cell
cell
treat
less
effect
ppmo
fig
data
shown
equal
volum
rtpcr
product
equival
number
infect
cell
pretreat
ppmo
faint
ie
sgrna
possibl
undetect
sgrna
fig
genom
rna
synthesi
likewis
qualit
reduc
ppmo
data
shown
errorpron
replic
rna
virus
present
rapid
model
viral
evolut
drug
resist
studi
order
assess
propens
sarscov
develop
resist
antisens
ppmo
stock
cultur
plaquepurifi
biolog
clone
sarscov
serial
passag
cell
pretreat
ppmo
viral
growth
assess
passag
fig
treatment
ppmo
strongli
inhibit
sarscov
growth
sever
passag
howev
increas
titer
indic
partial
resist
observ
seven
passag
sarscov
plaqu
purifi
round
ppmo
select
form
small
plaqu
cell
absenc
ppmo
fig
ppmoselect
sarscov
display
delay
growth
kinet
compar
untreat
sarscov
ppmoselect
sarscov
data
shown
rna
isol
plaqu
purifi
sarscov
select
round
serial
ppmo
treatment
rtpcr
amplicon
serial
ppmotreat
sarscov
sequenc
determin
whether
viru
undergon
mutat
ppmo
select
three
contigu
base
chang
ctc
aaa
posit
proxim
leader
tr
within
target
region
appear
amplicon
sarscov
fig
thermal
melt
curv
data
peptideconjug
pmorna
duplex
variabl
mismatch
lead
us
specul
three
mutat
target
site
reduc
effect
melt
temperatur
tm
h
moulton
et
al
construct
luciferas
report
gene
place
immedi
downstream
either
wildtyp
sarscov
tr
region
region
ctc
aaa
mutat
observ
ppmoselect
sarscov
clone
fig
ppmo
approxim
tenfold
less
activ
tr
target
compar
wildtyp
target
ec
nm
respect
decreas
sensit
ppmo
consist
reduc
ppmotarget
rna
duplex
stabil
sarscov
similar
observ
recent
report
escap
variant
resist
sirna
manuscript
prepar
ppmo
bind
affin
compar
use
report
figur
escap
sarscov
serial
ppmo
passag
titer
infecti
sarscov
grown
nine
round
treatment
select
ppmo
measur
tcid
titrat
error
bar
indic
standard
error
throughout
plaqu
morpholog
ppmoresist
sarscov
strain
assess
absenc
ppmo
mean
plaqu
diamet
shown
b
sarscov
strain
select
serial
ppmo
treatment
sequenc
region
compris
ppmo
bind
site
shown
c
sequenc
untreat
dscrtreat
sarscov
repres
wildtyp
sequenc
mutat
found
strain
underlin
sequenc
complementari
minussens
strand
antivir
effect
ppmo
consist
multipl
mechan
action
order
determin
whether
high
efficaci
could
attribut
steric
blockad
translat
report
construct
design
luciferas
express
initi
aug
codon
authent
sarscov
replicas
open
read
frame
aug
downstream
sarscov
region
ppmo
much
effect
ppmo
inhibit
report
translat
ec
nm
vs
nm
fig
target
site
base
suffici
distal
site
translat
initi
make
unlik
interfer
event
preiniti
terminu
eg
complex
load
onto
mrna
initi
initi
aug
eg
format
andor
join
ribosom
subunit
form
basi
observ
effect
therefor
conclud
ppmo
primarili
inhibit
sarscov
growth
interfer
translat
perhap
complex
scan
